Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Actelion To Acquire Trophos
Trophos’ compound Olesoxime has completed the recruitment of patients into a Phase III study in amyotrophic lateral sclerosis (ALS), an orphan disease also known as Lou Gehrig’s disease.
Trophos’ compound Olesoxime has completed the recruitment of patients into a Phase III study in amyotrophic lateral sclerosis (ALS), an orphan disease also known as Lou Gehrig’s disease.
Picasso 3 is designed to assess the safety and efficacy of Palifosfamide administered with doxorubicin compared with doxorubicin administered with placebo, with no crossover between arms. Picasso 3
Luigi Stasi, director of medicinal chemistry department at Rottapharm, said: “We are delighted to start an FTE-based collaboration with Selvita. We are keen to take advantage of Selvita’s
Eisai said that the oral suspension formulation was developed to provide a new treatment option for children four years and older and adults who have trouble swallowing tablets.
Most recently, Dr Duddu held the position of general manager and vice president of worldwide drug delivery technologies of Cima Labs, a wholly owned subsidiary of Cephalon. Prior
Mr Costello is expected to take up the responsibility to develop and manage key accounts within ET Horn’s Advanced Materials Group, which specialises in technical specialty chemicals helping
New Marketlink Pharmaceutical Corporation, a distributor of pharmaceutical and healthcare products in the Philippines and Inergetics’ marketing and distribution partner in the region, has activated a purchase order
Bioline manufactures and distributes specialised molecular biology reagents for the life science research, biotech, pharmaceutical, and commercial diagnostic markets in Germany, Australia, and the US. Meridian said that,
Sinobiopharma and Xianfeng said that Clindamycin is an antibiotic used to treat anaerobic bacterial infections. It can also be used to treat some protozoal diseases, such as malaria.
Net earnings and diluted earnings per share for the second quarter of 2010 were $3.4bn and $1.23, respectively. J&J said that excluding the special item, net earnings for